Regencell Bioscience Stock (NASDAQ:RGC)


ForecastOwnershipChart

Previous Close

$14.60

52W Range

$0.08 - $83.60

50D Avg

$15.41

200D Avg

$4.05

Market Cap

$5.12B

Avg Vol (3M)

$2.93M

Beta

2.62

Div Yield

-

RGC Company Profile


Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

HK

Employees

12

IPO Date

Jul 16, 2021

Website

RGC Performance


Peer Comparison


TickerCompany
RGSRegis Corporation
LIENChicago Atlantic BDC, Inc.
RGSRegis Corporation
NCMINational CineMedia, Inc.
VRPXVirpax Pharmaceuticals, Inc.
PAHCPhibro Animal Health Corporation
RNXTRenovoRx, Inc.
CNKCinemark Holdings, Inc.